Celestica's Next Rally Could Start Here (Q3 Earnings Preview)

Celestica shares have fallen 25% since the author's previous update despite accelerating earnings and repeated increases to management's full-year targets. The article says the $3 billion equity offering in August rattled shareholders but funded critical components that could support growth. Expanding 1.6T programs, OpenAI accelerator racks, AMD networking partnerships and 800G switches are cited as potential earnings opportunities through 2027.

Analysis

The key underwriting question is whether the equity raise converts into incremental, profitable shipments—not simply more capacity or inventory. Pre-buying scarce components can protect delivery schedules, but it also ties up cash and leaves Celestica exposed to customer-specific inventory if accelerator or networking deployments slip. Track cash conversion, inventory growth versus revenue, and diluted EPS—not headline target increases alone. The offering also raises the hurdle for per-share value creation: earnings growth must outpace dilution.

Near term, the prior share-price drawdown may leave room for a relief move if results confirm demand, but it does not establish cheapness without valuation and estimate data. Over 1–3 months, order conversion, component availability, and guidance quality matter more than announced programs. Over 6–18 months, successful 1.6T and accelerator-rack ramps could widen Celestica’s opportunity set; the counter-risk is that large customers retain bargaining power and shift production among contract manufacturers, limiting margin capture. AMD may benefit from more complete rack/networking deployments, but the partnership’s materiality to either company’s earnings remains unverified.

Contrarian point: the market may be discounting dilution and execution risk more than the growth pipeline, but the article’s optimistic claims are not independent evidence of backlog, margins, or cash returns. No high-conviction trade until those are checked.

Key Decisions for Investors

• Do not chase the drawdown on the article alone. Consider a staged, modest long in CLS only after a report confirms that revenue and diluted EPS are converting the expanded program pipeline into cash generation.
• Before adding, verify order/backlog conversion, customer concentration, component commitments, inventory and receivables trends, and the share-count impact of the offering. Rising inventory or receivables materially ahead of revenue would weaken the thesis.
• Treat AMD as a watch item rather than a direct read-through: seek evidence that the networking partnership is material to AMD shipments or economics before attributing meaningful earnings upside.
• Reassess or exit the bullish thesis if Celestica cuts targets, reports program delays or cancellations, or cash conversion deteriorates; a recovery in reported earnings without improvement in cash generation would not validate the funding thesis.